Outcome of non-metastatic male breast cancer: 118 patients

ÜY Arslan, B Öksüzoğlu, N Özdemir, S Aksoy, N Alkış… - Medical Oncology, 2012 - Springer
Studies concerning adjuvant systemic therapy and prognosis in male breast carcinoma
(MBC) are limited. We aimed to evaluate outcome of the changing practices of adjuvant …

Outcome of non-metastatic male breast cancer: 118 patients

U ARSLAN, B OKSUZOGLU, N OZDEMIR… - MEDICAL …, 2012 - avesis.erciyes.edu.tr
Studies concerning adjuvant systemic therapy and prognosis in male breast carcinoma
(MBC) are limited. We aimed to evaluate outcome of the changing practices of adjuvant …

[PDF][PDF] Outcome of non-metastatic male breast cancer: 118 patients

UY Arslan, B Oksüzoglu, N Ozdemir, S Aksoy, N Alkıs… - Med Oncol, 2012 - academia.edu
Studies concerning adjuvant systemic therapy and prognosis in male breast carcinoma
(MBC) are limited. We aimed to evaluate outcome of the changing practices of adjuvant …

Outcome of non-metastatic male breast cancer: 118 patients

ÜY Arslan, B Öksüzolu, N Özdemir, S Aksoy… - Medical …, 2012 - search.proquest.com
Studies concerning adjuvant systemic therapy and prognosis in male breast carcinoma
(MBC) are limited. We aimed to evaluate outcome of the changing practices of adjuvant …

Outcome of non-metastatic male breast cancer: 118 patients

UY Arslan, B Oksüzoğlu, N Ozdemir… - Medical oncology …, 2012 - pubmed.ncbi.nlm.nih.gov
Studies concerning adjuvant systemic therapy and prognosis in male breast carcinoma
(MBC) are limited. We aimed to evaluate outcome of the changing practices of adjuvant …

Outcome of non-metastatic male breast cancer: 118 patients.

UY Arslan, B Oksüzoğlu, N Ozdemir… - Medical Oncology …, 2011 - europepmc.org
Studies concerning adjuvant systemic therapy and prognosis in male breast carcinoma
(MBC) are limited. We aimed to evaluate outcome of the changing practices of adjuvant …

Outcome of non-metastatic male breast cancer: 118 patients

ÜY Arslan, B Öksüzoğlu, N Özdemir, S Aksoy, N Alkış… - Medical Oncology, 2012 - infona.pl
Studies concerning adjuvant systemic therapy and prognosis in male breast carcinoma
(MBC) are limited. We aimed to evaluate outcome of the changing practices of adjuvant …

Outcome of non-metastatic male breast cancer: 118 patients

U Arslan, B Oksuzoglu, N Ozdemir, S Aksoy… - MEDICAL …, 2012 - avesis.gazi.edu.tr
Studies concerning adjuvant systemic therapy and prognosis in male breast carcinoma
(MBC) are limited. We aimed to evaluate outcome of the changing practices of adjuvant …

[PDF][PDF] Outcome of non-metastatic male breast cancer: 118 patients

UY Arslan, B Oksüzoglu, N Ozdemir, S Aksoy, N Alkıs… - Med Oncol, 2012 - academia.edu
Studies concerning adjuvant systemic therapy and prognosis in male breast carcinoma
(MBC) are limited. We aimed to evaluate outcome of the changing practices of adjuvant …

Outcome of non-metastatic male breast cancer: 118 patients

ÜY Arslan, B Öksüzoğlu, N Özdemir, S Aksoy, N Alkış… - Medical Oncology, 2012 - infona.pl
Studies concerning adjuvant systemic therapy and prognosis in male breast carcinoma
(MBC) are limited. We aimed to evaluate outcome of the changing practices of adjuvant …